Squeeze vs The Tox
Squeeze vs The Tox: Squeeze costs $32K to $966K to open; The Tox costs $258K to $449K. Squeeze has 16 units, The Tox has 6. SBA loan history: Squeeze = 27 loans (0.0% default); The Tox = 7 loans (0.0% default). The franchise with more SBA funded units, a lower SBA default rate, and a lower royalty load is the safer financing bet; see the comparison below.
Squeeze vs The Tox: Capital, Scale & Lending Analysis
Analysis based on FDD filings and SBA 7(a) loan level data. Each pairing reflects a unique combination of capital intensity, system scale, and financing path.
Capital Intensity
Squeeze requires the lower minimum capital commitment ($32K vs $258K for The Tox), a 88% spread. Initial franchise fees come in at $60K for Squeeze versus $50K for The Tox, The Tox has the lower entry fee. Ongoing royalty load is 6% for Squeeze and 8% for The Tox, giving Squeeze the lighter per-unit drag on operating income.
System Scale & Tenure
On scale, Squeeze operates 16 units to The Tox's 6, roughly 3× the system size. The Tox has been operating 7 years (founded 2019) versus 7 for Squeeze (founded 2019), a 0-year tenure gap that affects unit-economics maturity and FDD revision history.
SBA Lending Profile
Squeeze has the deeper SBA lending track record, with 27 7(a) approvals compared with 7 for The Tox. Squeeze's peak SBA year was 2024 (15 loans); The Tox's peak was 2025 (5 loans). The Tox's more recent peak generally indicates fresher lender appetite. Squeeze has the most SBA funded units in CA, with 8. The Tox leads in OH, with 2. Borrowers should pick the brand whose strongest SBA state matches their own state for warmer lender introductions. Average SBA loan size on funded Squeeze deals is $480K vs $301K for The Tox, useful as a sizing anchor when modeling your own unit.
Risk Signal
SBA default rates are 0.0% for Squeeze and 0.0% for The Tox. PeerSense FPI scores come in at 69 (Strong) for Squeeze and 65 (Strong) for The Tox, giving Squeeze the stronger composite signal across SBA performance, lender appetite, and operational consistency.
Health & Performance
FPI Score | 69/100 | 65/100 |
Health Tier | Strong | Strong |
Confidence | N/A | N/A |
Lending Trend | N/A | N/A |
SBA Lending
SBA Loans | 27 | 7 |
SBA Volume | – | – |
Default Rate | 0.0% | 0.0% |
Peer Tier | established | emerging |
Investment & Costs
Total Investment | $32K to $966K | $258K to $449K |
Franchise Fee | $60K | $50K |
Royalty Rate | 6% | 8% |
Ad Fund | N/A | 2% |
Liquid Capital | N/A | N/A |
Net Worth Required | N/A | N/A |
Financial Performance (Item 19)
Item 19 Status | Not Disclosed | Disclosed |
System Size & Operations
Total Units | 16 | 6 |
Franchised Units | 16 | 6 |
Company Owned | – | – |
Term Length | N/A | 10 yrs |
Brand Information
Year Founded | 2019 | 2019 |
Franchising Since | N/A | 2021 |
Years Franchising | N/A | 5 yrs |
Headquarters | SAN MATEO, CA | Vero Beach, FL |
Category | Offices of All Other Miscellaneous Health Practitioners | Offices of All Other Miscellaneous Health Practitioners |
Website | ||
FDD Year | 2023 | 2025 |
Which Is Better, Squeeze or The Tox?
Lower upfront capital required
Squeeze
Squeeze: $32K starting · The Tox: $258K starting
More SBA lender confidence
Squeeze
Squeeze: 27 SBA loans · The Tox: 7 SBA loans
Lower SBA default rate
Tie
Squeeze: 0.0% · The Tox: 0.0%
Larger system & brand presence
Squeeze
Squeeze: 16 units · The Tox: 6 units
Lower ongoing royalty load
Squeeze
Squeeze: 6% · The Tox: 8%
More lender financing options
Squeeze
Squeeze: 6 unique lenders · The Tox: 3 unique lenders
Decision matrix uses publicly disclosed FDD and SBA loan data. Not a recommendation. Your best franchise depends on capital, market, operating capacity, and risk tolerance.
Need Funding for Squeeze or The Tox?
PeerSense connects you with 500+ SBA lenders and capital sources. Our referral fee is established upfront and paid at closing.
SBA Lenders & Capital Sources
Retainers or Consulting Fees
10% Down Franchise Loans
About These Franchises
Squeeze vs The Tox: Franchise Funding Comparison
Comparing Squeeze and The Tox is about more than brand preference. It's about which franchise fits your financial profile and funding strategy. Investment ranges from $32K to $966K.
Squeeze has 27 SBA loans on record and The Tox has 7. Those totals are cumulative history rather than a measure of current appetite. There is not enough recent lending activity on record to judge current appetite for at least one of these brands, so it has to be checked deal by deal.
SBA 7(a) loans are the most common franchise funding vehicle, offering up to $5M with as little as 10% down. PeerSense connects franchise buyers with the specific lenders who have approved loans for these brands, not generic referrals, but lenders with actual franchise lending track records.
Data sourced from SBA loan records, Franchise Disclosure Documents, and public filings. Updated regularly. Not financial advice, consult with a lending professional before making investment decisions.
Squeeze vs The Tox, Frequently Asked Questions
Which is a better franchise investment, Squeeze or The Tox?
How much does a Squeeze franchise cost compared to The Tox?
Can I finance Squeeze or The Tox with an SBA loan?
Which has a lower SBA default rate, Squeeze or The Tox?
Talk to PeerSense
Tell us which brand and your budget. We source capital from lenders who have already funded deals in these systems.
Franchise / SBA 7(a): The desk will reach out. No obligation.
Page Review
Reviewed by Edward L. Freeman, Founder and Managing Director, PeerSense
- PeerSense is a capital advisory firm that places commercial financing with direct capital sources; the capital source sets final terms.
- Edward L. Freeman founded PeerSense in January 2020.
- He is a Registered Franchise Consultant with Business Alliance, Inc., a credential issued in March 2022, and worked as a franchise consultant there from March 2022 to May 2023.
- His recorded experience includes a $22 million SBA construction loan, with about $16 million funded on the deal.
- In the 12 months through September 30, 2026, PeerSense tracked 912 publicly announced financings with a disclosed size of $361.32 billion. PeerSense Capital Data Report · Methodology page
Last reviewed LinkedIn profileAbout Edward Freeman